Premium
Performance of the Baxter disposable patient‐controlled analgesia infusor under hyperbaric conditions
Author(s) -
RADCLIFFE J. J.,
SPENCER I.
Publication year - 1994
Publication title -
anaesthesia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.839
H-Index - 117
eISSN - 1365-2044
pISSN - 0003-2409
DOI - 10.1111/j.1365-2044.1994.tb04456.x
Subject(s) - medicine , propofol , anesthesia , hyperbaric oxygen , surgery
Summary Hyperbaric oxygen treatment may require the concurrent administration of drugs. A study was performed to assess the suitability of the infusor device from the Baxter Patient‐Controlled Analgesia system, for drug delivery during hyperbaric therapy. Thirty infusor devices were used to deliver 5% dextrose, 50% dextrose or propofol solutions under conditions of 1 and 2.3 atmospheres of pressure. The increased pressure caused an increase inflow of 4.27%, 1.79% and 9.84% for 5% dextrose, propofol and 50% dextrose respectively.